BrainStorm Cell Therapeutics
BCLI
#10765
Rank
NZ$17.13 M
Marketcap
NZ$1.55
Share price
-9.73%
Change (1 day)
24.98%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$20.3 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total liabilities are NZ$20.3 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BrainStorm Cell Therapeutics - Total liabilities on balance sheet (from 2002 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$19 M11.7%
2024-12-31NZ$17.01 M18.69%
2023-12-31NZ$14.33 M-20.62%
2022-12-31NZ$18.05 M24.16%
2021-12-31NZ$14.54 M-33.56%
2020-12-31NZ$21.89 M-21.4%
2019-12-31NZ$27.85 M200.73%
2018-12-31NZ$9.26 M18.66%
2017-12-31NZ$7.8 M525.73%
2016-12-31NZ$1.24 M-71.08%
2015-12-31NZ$4.31 M4.43%
2014-12-31NZ$4.13 M70.81%
2013-12-31NZ$2.41 M72.07%
2012-12-31NZ$1.4 M-12.68%
2011-12-31NZ$1.6 M-19.8%
2010-12-31NZ$2 M-41.7%
2009-12-31NZ$3.44 M-32.31%
2008-12-31NZ$5.08 M10.94%
2007-12-31NZ$4.58 M27.18%
2006-12-31NZ$3.6 M
2006-03-31NZ$14.49 M5792.37%
2005-03-31NZ$0.24 M244.39%
2004-03-31NZ$0.07 M57.35%
2003-03-31NZ$0.04 M74.06%
2002-03-31NZ$0.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Biogen
BIIB
NZ$18.69 B 91,972.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$56.68 B 279,116.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
NZ$1.87 B 9,113.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$3.62 B 17,751.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.71 B 3,422.94%๐Ÿ‡บ๐Ÿ‡ธ USA